Prism Research and MD Biosciences Receive First Contract Award as Members of the Minnesota Clinical Research Hub (MCRH)
Minnesota Clinical Research Hub (MCRH) today announced its first contract for a multi-site, Phase I clinical research study. The contract was awarded to Prism Research and MD Biosciences, both based in St. Paul, MN and two of MCRH’s founding members.
New Clinical Research Consortium Provides Integrated Development Platform in Medical Alley
Prism Research is one of 5 leading Minnesota based research organizations that have partnered to provide the most comprehensive clinical development platform in the industry. To find out more, click the link below.
7- Signs of Liver Problems
Prism is now conducting studies for volunteers with liver impairment. Quick- read- article to address 7 signs of a bad liver condition.
DaVita Clinical Research and Prism Clinical Research choose Verified Clinical Trials to prevent duplicate enrollment in clinical trials
MINNEAPOLIS (Jan. 17, 2017) – DaVita Clinical Research (DCR), a specialty contract research organization with services spanning the full spectrum of drug and device development, and Prism Clinical Research, a leader in providing fully integrated clinical research services to pharma/device companies and clinicians, today announced Verified Clinical Trials (VCT) has been selected by both companies as an exclusive provider to further prevent duplicate enrollment in clinical trials.
Simultaneously enrolling in multiple clinical trials, or duplicate enrollment, has become a serious problem in the clinical research world. A growing number of research volunteers attempt to jump from one study to another without waiting for the appropriate amount of time to lapse. This creates dangerous issues for the drug manufacturer, the research site, the data quality, and, most importantly, the volunteer.
“We are pleased to have these two clinical research leaders join out network,” said Dr. Mitchell Efros, CEO of VCT. “Our system will allow both companies to take big steps forward in preventing duplicate enrollment and the risks associated.”
VCT maintains a global clinical trial research subject database registry to counter attempts at duplicate enrollment in clinical trial research. The majority of phase I units and an increasingly large number of late phase sites in North America use Verified Clinical Trials, making VCT by far the largest North American clinical research subject database registry in both early and late phase clinical trials.
“DCR is passionate about ensuring data quality and research subject safety,” said Amy Young, vice president and general manager of DCR. “Partnering with Prism and using the VCT system is the right thing to do for all our stakeholders.”
Experts and leaders in the field of hepato-renal clinical trials, Prism and DCR join a vast network of research sites and pharmaceutical companies in their efforts to prevent duplicate enrollment and other important protocol violations in clinical trials.
”Prism is glad to be participating in this joint effort with our research neighbor, DCR,” said Jeff Cosgrove, president of Prism Research. “We’ve always been proactive in combating dual enrollment, but VCT gives us state-of-the-art technology and processes toward that end.”
Located in close proximity to the Minneapolis and St. Paul metropolitan area, Prism and DCR specialize in early phase clinical research in healthy volunteer trials and many patient-based volunteer trials, including those in hepatic and renal insufficiency populations.
About Prism Clinical Research
Prism Clinical Research is a Twin Cities–based clinical research company committed to the advancement of improved medical knowledge and the community’s health. Since 2005, Prism has provided FDA-approved, investigational pharmaceutical and medical device testing services on behalf of drug and device manufacturers, academic and private physicians, as well as other researchers across Minnesota.
About DaVita Clinical Research
DaVita Clinical Research (DCR), a wholly owned subsidiary of DaVita Inc., uses its extensive, applied database and real-world healthcare experience to assist pharmaceutical and medical device companies in the design, recruitment and completion of retrospective, prospective and pragmatic clinical trials. DCR’s scientific and clinical expertise spans the lifecycle of product development with more than 175 client companies. DCR’s Early Clinical Research unit (Phase I-IIa) and Late Phase Clinical Research (Phase IIb through post-marketing) network of physicians and investigative sites, and Real World Healthcare Data are focused on providing world-class research in both complex/specialty populations and therapeutic areas, and especially in CKD and ESRD populations. To learn more about DCR, visit http://www.davitaclinicalresearch.com.
About Verified Clinical Trials
Verified Clinical Trials is a forward thinking company developed by experts active in the clinical research community to proactively improve research subject safety and data quality in clinical research trials. Verified Clinical Trials halts duplicate enrollment in clinical trials and defines itself as the world’s leader in the field of database registries in clinical trial research. Verified Clinical Trials is the only clinical research database registry designed specifically to enhance the quality of both early and late phase trials, and has the scalability to reach all sites nationally as well as on a global level. Verified Clinical Trials offers numerous other value-added services to the clinical research site, CRO, and Pharmaceutical Sponsor that prove invaluable with regards to financial and legal issues and liabilities. Verified Clinical Trials prevents several other key protocol deviations. For more information, RSVP to or visit
BMI 101: What's in a number?
BMI stands for "Body Mass Index," and it's a calculation determined by your heigh and weight. There is almost always a BMI range in Prism's studies. And, let's be honest, for many of us that range can be a tight fit.
Why does the BMI range exist? To provide an expected norm within which the population of participants will fall.
Why is there a BMI limit? A participant with a higher BMI may require a greater dose of the study drug and therefore may metabolize the drug differently than a person with a lower BMI.
Why does the BMI range change from study to study? The range is determined by the study sponsor - the company paying Prism Research to conduct the study. The range is based on the type of study, the procedures being done, and the study drug.
Prism Rides "Tour de Cure"
Prism staff took part in the American Diabetes Association's "Tour de Cure" June 1st. Our ride wasn't the end of our organization's efforts to stop diabetes. We're advancing diabetes research right here in St. Paul!
If you or a loved one suffers from diabetes, consider telling them about Prism's continued commitment to offer studies for diabetics.
OmniComm Systems, Inc. Celebrates Innovation and Excellence at Third Annual Innovation Forum
Prism Research receives Innvovation and Excellence Award! http://www.omnicomm.com/press/2013_11_22__OmniComm_Systems_Celebrates_Innovation_and_Excellence_at_Third_Annual_Innovation_Forum.html
Our Hometown -The Twin Cities
We love being a part of the Twin Cities metro for so many reasons. Great food, great lakes, but most importantly great volunteers and people. Below is a link to why hometown foodie Andrew Zimmern loves the Twin Cities!